Medexus Pharmaceuticals Inc (MDP.WT) News

Form F-1 - Registration statement for certain foreign private issuers

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

VIVOPOWER SECURES EXTENSION FOR US$34M LOAN FINANCING FACILITY AGREEMENT

Agreement consolidates major shareholder loan into single US$34m tranche Extends tenure of non-dilutive...

One Month Exclusive Agreement Extension Sends Micro Cap Flying

Every now and then a press release will come across the desk that make traders go into an absolute buying frenzy. This is particularly true if the...

VIVOPOWER’S TEMBO CONFIRMS HEADS OF AGREEMENT EXCLUSIVITY EXTENSION FOR US$838M MERGER WITH CCTS (UPDATED)

Exclusivity period for Heads of Agreement extended to 31 July 2024 LONDON, July 03, 2024 (GLOBE NEWSWIRE...

VIVOPOWER’S TEMBO CONFIRMS HEADS OF AGREEMENT EXCLUSIVITY EXTENSION FOR US$838M MERGER WITH CCTS

Exclusivity period for Heads of Agreement extended to 31 July 2024 LONDON, July 02, 2024 (GLOBE NEWSWIRE...

VIVOPOWER ANNOUNCES COMPLETION OF KENSHAW SALE

LONDON, July 02, 2024 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR, "VivoPower” or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

VIVOPOWER’S TEMBO SECURES 200 TUSKERS WORTH US$10M

Tembo has secured a minimum of 200 Tuskers for the Australia and NZ markets Australian sales of pick up trucks...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]